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Prepregnancy overweight and obesity are associated with higher risk of perinatal
complications. However, the effect of weight change prior to pregnancy on perinatal
outcome is largely unknown. Therefore, it is aimed to examine the impact on perina-
tal outcomes of interpregnancy BMI change in women of different BMI categories.
The MEDLINE, EMBASE, LILACS, and CINAHL databases were searched (1990‐
August 2019). Observational studies on interpregnancy BMI change were selected.
Outcomes evaluated were gestational diabetes mellitus (GDM), preeclampsia, gesta-
tional hypertension (GH), cesarean section, preterm birth, and newborns being large
(LGA) or small (SGA) for gestational age. Meta‐analyses and meta‐regression analyses
were executed. Thirty studies were included (n > 1 million). Interpregnancy BMI gain
was associated with a higher risk of GDM (for BMI gain ≥3 kg/m2: OR 2.21; [95%CI
1.53‐3.19]), preeclampsia (1.77 [1.53‐2.04]), GH (1.78 [1.61‐1.97]), cesarean section
(1.32 [1.24‐1.39]), and LGA (1.54 [1.28‐1.86]). The effects of BMI gain were most
pronounced in women with BMI <25 kg/m2 before the first pregnancy regarding
GDM, GH, and cesarean section. Except for LGA, interpregnancy BMI loss did not
result in a decreased risk of perinatal complications. In this study, women of normal
weight who gain weight before pregnancy were identified as a high‐risk population
for perinatal complications. This emphasizes that weight management is important
for women of all BMI categories and a pregnancy wish.
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WE I GH T CHANG E / P R E GNANCY OUT COME S
1 | BACKGROUND
The prevalence of overweight and obesity in women of reproductive
age has reached epidemic proportions and is associated with health
risks for both mother and child. Risk factors including maternal
overweight and obesity immediately before pregnancy and excessive
gestational weight gain have been associated with adverse perinatal
outcomes, such as gestational diabetes mellitus (GDM), preeclampsia,
cesarean section, large (LGA) and small (SGA) for gestational age, and
preterm birth.1-3 These risk factors are often preceded by a certain
lifestyle including unhealthy food and insufficient physical activity.4,5
In turn, these lifestyle‐related environmental exposures during fetal
and neonatal development can lead to epigenetic changes resulting
in fetal and metabolic programming.6 This programming influences
the risk of cardiometabolic derangements and subsequent
noncommunicable diseases in childhood and adult life and contrib-
utes therefore to the intergenerational transmission of health
risks.6-8 It is however unknown whether these adverse effects of
overweight and obesity are caused merely by the static situation
of the body mass index (BMI) that women have at the start of their
pregnancy, or that these are the result of an increase in BMI in the
period prior to pregnancy. At the same time, the effects of weight
reduction in the preconception phase are an unexplored field as well.
Although the World Health Organization emphasizes the need
for preconception care,9 there is still a lack of studies regarding
the effects of preconception weight change and lifestyle interven-
tions on perinatal outcome. As a substitute, interpregnancy weight
change—defined as change in maternal preconception weight from
first to second pregnancies—offers a unique opportunity to collect
data on weight change before the subsequent pregnancy. Therefore,
the aim of this review is to study the impact of interpregnancy
weight or BMI change between two consecutive pregnancies on
perinatal outcomes in women with underweight, normal weight,
overweight, and obesity before the first pregnancy.
2 | METHODS
A protocol for this systematic review and meta‐analysis was
prospectively registered in the International Prospective register of
systematic reviews (PROSPERO; 2016: CRD42016043307).10
2.1 | Search strategy
The MEDLINE (Ovid; search strategy in Text S1), EMBASE (Ovid),
LILACS, and CINAHL databases were searched for relevant studies
from 1990 to August 2019. The following keywords and variations
of these terms were included: “body weight,” “weight loss,” “weight
gain,” “obesity,” “body mass index,” “change,” “birth intervals,”
“consecutive pregnancies,” and “between gestation.” The searches
were limited to human studies. The search strategy was verified by
an information specialist using the Peer Review of Electronic Search
Strategies (PRESS) checklist.11
2.2 | Study eligibility criteria
To answer the prognostic research question, observational
(longitudinal, cohort, and case‐control) studies were included. An
article was considered eligible and was included if it concerned the
difference in prepregnancy weight or BMI between two consecutive
singleton pregnancies. In order to answer the research question for
the general population, studies were excluded in which only women
with perinatal complications in the first pregnancy had been included.
Studies were excluded if they did not report on any of the following
outcomes of interest: GDM, gestational hypertension (GH),
preeclampsia, caesarean section, preterm birth, SGA, and LGA.
Inclusion of studies was not restricted by language, publication date,
country, or duration of the interpregnancy interval.
Titles and abstracts of studies retrieved from the search strategy
and, subsequently, full texts of potentially eligible studies were
screened independently by two reviewers (YT and EO). Any
disagreement regarding eligibility was discussed with a third reviewer
until consensus was reached.
2.3 | Quality assessment and data synthesis
Meta‐analyses were performed where possible: when at least two
studies used the same outcome parameters and comparable catego-
ries of weight or BMI change. Odds ratios (ORs) adjusted for potential
confounders were extracted from the studies and included in the
meta‐analysis that reported these data. Where needed, the number
of events in each BMI change category was calculated based on the
provided adjusted ORs in the studies. In some cases, BMI change
categories were merged in order to equalize BMI change categories
of different studies, which enabled the combination of these studies
in a meta‐analysis. The reference group was defined as BMI change
between −1 and 1 kg/m2 or −2 and 2 kg/m2, dependent on the
reference groups used in the original studies. Pooled ORs with 95%
confidence intervals (95%CI) were calculated by using Comprehensive
Meta‐Analysis V 3.0 software (Biostat Inc, Englewood, NJ, USA) from
studies that reported raw data. Due to the heterogeneity anticipated,
summary statistics were calculated with a random effects model.
Statistical heterogeneity was assessed by the I2 statistic, which
describes the proportion of variance (from 0% to 100%) that is due
to variance in true effect sizes rather than sampling error.12 Meta‐
regression was used to determine if differences in effect sizes
between various weight or BMI loss and/or gain categories were sig-
nificant. Specifically, for each pair of weight or BMI gain/loss sub-
groups used by studies to report on an outcome (eg, BMI
maintenance between −1 and 1 kg/m2 vs BMI gain between 1 and 3
kg/m2) we used meta‐regression to determine if the differences in
effect size varied significantly across subgroups. A p‐value < 0.05
was considered statistically significant. When studies reported on rel-
evant outcomes but their data could not be aggregated with other
studies, these results were presented as a narrative review. A sensitiv-
ity analysis was performed to take the quality of the studies into
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account. The analysis of all studies was compared to the analysis on
studies qualified as low or moderate risk of bias to identify the impact
of the level of bias on summary effects.
The quality of studies was independently assessed by two
reviewers (YT and EO; see Table S2) using the validated Quality In
Prognostic Studies (QUIPS) tool.13 Based on the items mentioned in
this tool, the risk of bias was determined. For assessment of
agreement between the two reviewers, the inter‐rater agreement of
the QUIPS tool was evaluated. An online kappa calculator was used
to calculate Cohen's kappa with quadratic weighting (http://
vassarstats.net/kappa.html) for all domains of the QUIPS tool
combined. Disagreements between the review authors were resolved
by discussion with a third reviewer (KK) until consensus was reached.
3 | RESULTS
3.1 | Study selection
A total number of 16,223 articles were retrieved from the search.
After removal of duplicates, 12,303 titles and abstracts were eligible
for screening. In 122 studies, full text was assessed for eligibility, of
which 30 articles were included in this review and eleven articles were
included in the meta‐analyses (see PRISMA flow diagram14; Figure 1).
3.2 | Study characteristics
The study population, study design, setting, exposure, and outcome
measurements are summarized in Tables S1 to S7. All studies were
reported between 2002 and 2019 and were executed in European
countries, Australia, or the USA with sample sizes ranging from 537
to 465,836 women. The majority of studies were retrospective, and
confounders such as smoking status, interpregnancy interval, and
BMI at the index pregnancy were controlled for in most studies. In
general, the studies included used two different forms of categoriza-
tion of interpregnancy weight change: (1) change in BMI (in kg/m2)
between pregnancies; (2) change in BMI category (underweight,
normal weight, overweight, and obesity) between pregnancies.
3.3 | Data extraction
In Figures 2 and 3, pooled adjusted ORs are shown for the association
between interpregnancy BMI change and adverse perinatal outcomes.
Figures S1 to S7 show forest plots for each individual outcome.
Table 1 shows the results of the meta‐regression analyses.
FIGURE 1 Flowchart of literature search according to the PRISMA flow diagram. n = number. *Exact breakdown for exclusion not documented
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3.3.1 | Gestational diabetes mellitus
Eleven studies assessed GDM,15-20 of which five studies21-25 were
eligible for the meta‐analysis. The meta‐analysis found a significant,
positive association between interpregnancy BMI gain and GDM
development during the second pregnancy (Figure S1: OR 1.64 [95%
CI 1.28‐2.11]; I2 = 78% for BMI gain of 1 to 3 kg/m2; OR 2.42
[1.62‐3.62]; I2 = 89% for BMI gain of ≥3 kg/m2). In contrast, BMI loss
FIGURE 2 Pooled adjusted odds ratios (aORs) are shown for the association between different categories of BMI change between pregnancies
with maternal pregnancy outcomes. Reference group is BMI maintenance (between −1 and 1 kg/m2). BMI, body mass index; GDM, gestational
diabetes mellitus; GH, gestational hypertension; 95%CI, 95% confidence interval
FIGURE 3 Pooled adjusted odds ratios (aORs) are shown for the association between different categories of BMI change between pregnancies
with children's pregnancy outcomes. Reference group is BMI maintenance. aReference group is BMI maintenance between −2 and 2 kg/m2.
bReference group is BMI maintenance between −1 and 1 kg/m2. BMI, body mass index; LGA, large for gestational age; SGA, small for gestational
age; 95%CI, 95% confidence interval
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of ≥1 kg/m2 was not significantly associated with the risk of GDM
(Figure S1: OR 0.77 [0.48‐1.21]; I2 = 79%). Meta‐regression showed
that the effect size on GDM in women who lost ≥1 kg/m2 between
pregnancies was significantly lower than women who gained 1 to 3
kg/m2 (p = 0.004) or ≥3 kg/m2 (p < 0.0001). No difference in effect
size was found between women with BMI gain of 1 to 3 kg/m2 and
women with BMI gain of ≥3 kg/m2 (p = 0.074; Table 1). In the studies
of Glazer et al15 Knight‐Agarwal et al16 McBain et al17 Lu et al18
Whiteman et al19 and Bender et al20 (not included in the meta‐
analysis), the results were comparable to the meta‐analysis. It was
demonstrated that the effects of interpregnancy BMI gain on the risk
for developing GDM were highest in women with normal weight
before the first pregnancy (Table S8).17,21-23 For mothers with
overweight or obesity before the first pregnancy, interpregnancy
BMI loss decreased the risk of GDM.17,22 Changing to a lower BMI
category decreased the risk of developing GDM.19
3.3.2 | Gestational hypertension
In six studies, GH was assessed.20,21,23,24,26,27 Four studies were
included in the meta‐analysis,21,23,24,27 which resulted in a nonsignifi-
cant effect for BMI loss of ≥1 kg/m2 (Figure S2: OR 1.07 [0.85‐1.34];
I2 = 42%) on the development of GH. Increasing interpregnancy BMI
gain was associated with a significantly increased risk of GH develop-
ment (Figure S2: OR 1.49 [1.34‐1.66]; I2 = 0% for BMI gain of 1 to 3
kg/m2; OR 1.98 [1.56‐2.50]; I2 = 62% for BMI gain of ≥3 kg/m2).
TABLE 1 Meta‐regression to determine differences between subgroups
Coefficient 95%CI p‐value
GDM
BMI gain of 1 to 3 kg/m2 vs BMI loss of >1 kg/m2 −0.58 −0.97 to −0.18 0.004
BMI gain of 1 to 3 kg/m2 vs BMI gain of ≥3 kg/m2 0.37 −0.04 to 0.77 0.074
BMI loss of >1 kg/m2 vs BMI gain of ≥3 kg/m2 0.94 0.55 to 1.35 <0.0001
GH
BMI gain of 1 to 3 kg/m2 vs BMI loss of > 1 kg/m2 −0.34 −0.60 to −0.09 0.008
BMI gain of 1 to 3 kg/m2 vs BMI gain of ≥ 3 kg/m2 0.29 0.05 to 0.54 0.019
BMI loss of >1 kg/m2 vs BMI gain of ≥ 3 kg/m2 0.64 0.38 to 0.90 <0.0001
Preeclampsia
BMI gain of 1 to 3 kg/m2 vs BMI loss of > 1 kg/m2 −0.32 −0.54 to −0.10 0.005
BMI gain of 1 to 3 kg/m2 vs BMI gain of ≥ 3 kg/m2 0.32 0.12 to 0.52 0.002
BMI loss of >1 kg/m2 vs BMI gain of ≥ 3 kg/m2 0.64 0.41 to 0.87 <0.0001
Cesarean section
BMI gain of 1 to 3 kg/m2 vs BMI loss of > 1 kg/m2 −0.11 −0.21 to −0.01 0.027
BMI gain of 1 to 3 kg/m2 vs BMI gain of ≥ 3 kg/m2 0.15 0.06 to 0.25 0.001
BMI loss of >1 kg/m2 vs BMI gain of ≥ 3 kg/m2 0.27 0.16 to 0.37 <0.0001
Preterm birth
BMI gain of 2 to 4 kg/m2 vs BMI loss of > 2 kg/m2 −0.03 −0.41 to 0.36 0.880
BMI gain of 2 to 4 kg/m2 vs BMI gain of ≥ 4 kg/m2 −0.07 −0.45 to 0.32 0.727
BMI loss of >2 kg/m2 vs BMI gain of ≥ 4 kg/m2 −0.04 −0.43 to 0.36 0.849
SGA
BMI loss of >2 kg/m2 vs BMI gain of ≥ 2 kg/m2 −0.03 −0.28 to 0.22 0.802
LGA
BMI loss of >2 kg/m2 vs BMI gain of 1 to 3 kg/m2 0.59 0.27 to 0.92 0.0003
BMI loss of >2 kg/m2 vs BMI gain of ≥ 3 kg/m2 0.86 0.53 to 1.19 <0.0001
BMI gain of 1 to 3 kg/m2 vs BMI loss of > 1 kg/m2 v0.63 −0.93 to −0.33 <0.0001
BMI gain of 1 to 3 kg/m2 vs BMI gain of ≥ 3 kg/m2 0.27 −0.02 to 0.56 0.072
Note: Meta‐regression was used to determine if subgroups were significantly different in effect size. The coefficient is the difference in odds ratio between
subgroups. Significant probability values indicate that the two groups compared were significantly different in the outcome studied. The first subgroup that
is mentioned is used as reference group.
Abbreviations: BMI, body mass index; 95%CI, 95% confidence interval; GDM, gestational diabetes mellitus; GH, gestational hypertension; LGA, large for
gestational age; SGA, small for gestational age.
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Meta‐regression found that effect sizes were significantly different
between subgroups (Table 1). The lowest effect size was found for
the subgroup of BMI loss of ≥1 kg/m2 and the highest effect size
for the subgroup of BMI gain of ≥3 kg/m2 (Figure 2). The studies of
Hoff et al26 and Bender et al20 which were not included in the
meta‐analysis, found no effect of weight change between pregnancies
on GH. The studies of Villamor and Cnattingius,23 Lynes et al24 and
Wallace et al27 showed that, in women who started with normal
weight, interpregnancy BMI gain resulted in a higher risk of developing
GH during the second pregnancy compared to women who started
with overweight or obesity (Table S9).
3.3.3 | Preeclampsia
Six studies assessed preeclampsia as an outcome.23,24,27-30 Three
studies were included in the meta‐analysis,23,24,27 which found no
effect for preeclampsia after loss of >1 kg/m2 between pregnancies
(Figure S3: OR 0.84 [0.69‐1.01]; I2 = 0%). An increased risk for devel-
oping preeclampsia during the second pregnancy was found for
interpregnancy BMI gain of 1 to 3 kg/m2 (Figure S3: OR 1.36 [1.22‐
1.53]; I2 = 0%) and an even higher risk was found for BMI gain ≥3
kg/m2 (OR 1.77 [1.53‐2.04]; I2 = 0%). Meta‐regression found that
the subgroup of BMI loss of >1 kg/m2 between pregnancies had a sig-
nificantly lower effect size compared to both subgroups of BMI gain of
1 to 3 kg/m2 (p = 0.005) and BMI gain of ≥3 kg/m2 (p < 0.0001). The
difference in effect size of the subgroup of BMI gain of 1 to 3 kg/m2
and the subgroup of BMI gain of ≥3 kg/m2 (p = 0.002) was significant
as well (Table 1). In the study of Jain et al28 (not included in the meta‐
analysis), significantly different prevalence rates of preeclampsia
between women with BMI loss of >2 kg/m2 (5.2%), BMI maintenance
(6.1%), and BMI gain of ≥2 kg/m2 (7.1%) were shown. Getahun et al29
demonstrated that overweight or obesity in either the first or the
second pregnancy was associated with an increased risk for
preeclampsia, independent of BMI gain or loss between pregnancies
(Table S10). The effect of interpregnancy BMI gain was strongest in
women with overweight or obesity.27
3.3.4 | Cesarean section
Ten studies included cesarean section as an outcome,16,20,24,26,31-33 of
which four studies were eligible for meta‐analysis.21,23,24,27 The meta‐
analysis showed no effect of BMI loss ≥1 kg/m2 (Figure S4: OR 1.01
[0.91‐1.11]; I2 = 40%) on the prevalence of a cesarean section. Higher
interpregnancy BMI gain was associated with a higher risk of a
cesarean section at the end of the second pregnancy (OR 1.14
[1.05‐1.24]; I2 = 51% for BMI gain of 1 to 3 kg/m2; OR 1.33 [1.19‐
1.48]; I2 = 50% for BMI gain of ≥3 kg/m2). Meta‐regression showed
that effect sizes varied significantly per subgroup (Table 1). The lowest
effect size was found for BMI loss of ≥1 kg/m2 and the highest effect
size for BMI gain of ≥3 kg/m2 (Figure 2). In the study of Dude et al31
(not included in the meta‐analysis), a decreased risk of a cesarean sec-
tion after BMI loss of >2 kg/m2 between pregnancies was shown.
Furthermore, interpregnancy weight gain resulted in an increased risk
of a cesarean section.31 The studies of Knight‐Agarwal et al16 Hoff
et al26 and Bender et al20 which were not included in the meta‐
analysis as well, showed no significant effects of BMI change and
BMI category shift between two pregnancies on the risk of cesarean
section in the second pregnancy. On the other hand, Getahun et al32
and Whiteman et al33 did show a significant effect of a BMI shift
between pregnancies from all BMI categories before the first preg-
nancy to becoming affected by overweight or obesity before the sec-
ond pregnancy on the risk of a cesarean section. Women of normal
weight before the first pregnancy who changed BMI in any direction
between the pregnancies had a significantly higher risk of an emer-
gency cesarean section in the second pregnancy compared to women
with overweight or obesity before the first pregnancy (Table S11).27
3.3.5 | Preterm birth
Eleven studies analyzed preterm birth as an outcome.17,20,26,27,34-40
Four of these studies were included in the meta‐analysis.17,27,39,40
Meta‐analysis demonstrated that interpregnancy BMI loss of >1
kg/m2 was associated with a higher risk of preterm birth (Figure S5:
OR 1.41 [1.06‐1.89]; I2 = 72%). Other BMI change categories were
not associated with the risk of preterm birth. Studies not included in
the meta‐analysis demonstrated no effect of BMI change between
pregnancies on preterm birth.20,26,27,34-38 Women with underweight
or normal weight before the first pregnancy, were at highest risk for
preterm birth when losing weight between pregnancies (Table
S12).27,40 A lower risk for spontaneous preterm birth, though a higher
risk for medically indicated preterm birth, was found in women
becoming affected by overweight or obesity before the second preg-
nancy or gaining weight between pregnancies.36 Interestingly, women
with overweight or obesity before the first pregnancy who lost weight
were at higher risk for preterm birth between 32 and 36 weeks of ges-
tational age.39
3.3.6 | Small for gestational age
In six studies, SGA was assessed.17,26-28,41,42 Two of the studies were
included in the meta‐analysis.17,28 In this analysis, it was shown that
BMI loss of >1 kg/m2 was related to a higher risk of SGA (Figure S6:
OR 1.58 [1.26‐1.98]; I2 = 84%). BMI loss of >2 kg/m2 and none of
the BMI gain categories were associated with SGA. When considering
the studies not included in the meta‐analysis, both studies of Wallace
et al originated from the same data source.27,42 Therefore, it was
decided to exclude the data of Wallace et al42 (2017) from the data
extraction because of a higher sample size in the other study of Wal-
lace et al27 (2014) while both studies were of equal quality. Hoff
et al26 and Cheng et al41 (not included in the meta‐analysis) showed
similar findings as the results of the meta‐analysis. Wallace et al27
found that women with decreasing interpregnancy BMI had a higher
risk of SGA, whereas women with increasing BMI had a lower risk of
SGA. Sensitivity analyses resulted in an increased risk for SGA after
weight loss between pregnancies in the case of women who had an
initial BMI <25 kg/m2 (Table S13).17,27,40 Contrasting results on risks
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of SGA were found for women who had overweight or obesity before
the first pregnancy and lost weight between pregnancies.17,27
3.3.7 | Large for gestational age
Eight studies were included in the data extraction for LGA26,43 of
which six studies were included in meta‐analysis.17,23,27,28,40,44
BMI loss of >2 kg/m2 did not result in a significant effect on LGA
(BMI change between −2 and 2 kg/m2 was used as reference) while
BMI loss of >1 kg/m2 did result in a significant decreased effect
(Figure S7: OR 0.80 [0.66‐0.98]; I2 = 95%; BMI change between
−1 and 1 kg/m2 was used as reference). This can potentially be
caused by a lack of power due to a low number of events in the
meta‐analysis for BMI loss of >2 kg/m2. In all cases, BMI gain
resulted in an increased risk for LGA (OR 1.33 [1.11‐1.60]; I2 = 0%
for BMI gain of 1 to 3 kg/m2; OR 1.28 [1.10‐1.50]; I2 = 58% for
BMI gain of ≥2 kg/m2; OR 1.54 [1.28‐1.86]; I2 = 0% for BMI gain
of ≥3 kg/m2). Both the effect sizes of the subgroup with BMI loss
of >2 kg/m2 (p = 0.003) and the subgroup with BMI loss >1 kg/m2
(p < 0.0001) were significantly different from the subgroup with
BMI gain of 1 to 3 kg/m2. No significant difference in effect size
was found between subgroups of BMI gain of 1 to 3 kg/m2and
BMI gain ≥3 kg/m2 (p = 0.072; Table 1). When considering the
results of the study of Getahun et al43 (not included in the meta‐
analysis), the risk of LGA was reduced in women with underweight
or normal weight before the first and second pregnancy, while an
increased risk was found in most other BMI category shift options.
Hoff et al26 found no differences between women who were over-
weight before the first pregnancy and shifted to other BMI catego-
ries before the second pregnancy. A decreased risk was found for
LGA after weight loss between pregnancies and an increased risk
after weight increase both for women with a BMI < 25 kg/m2 and
women with a BMI ≥25 kg/m2 before the first pregnancy (Table
S14).23,27,40,44 McBain et al did not find significant results in these
sensitivity analyses.17
3.4 | Risk of bias
Cohen's kappa coefficient of all domains of the QUIPS tool was 0.75
(95%CI 0.61‐0.89). Seven studies included in the meta‐analysis and
three studies not included in the meta‐analysis were assessed as
having a low risk of bias. Eleven studies were assessed as having a
moderate risk of bias of which four studies were included in the
meta‐analysis. Nine studies, all not included in the meta‐analysis, had
a high risk of bias (Table S15). Most studies properly described the
process of the databases and statistical models used. The most
commonly found risk of bias was related to self‐reported
prepregnancy weight and height and was thus not based on objective
measures. Furthermore, most of the studies with a high risk of bias
had insufficiently adjusted for possible confounders. Excluding the
studies with a high risk of bias did not affect the results for GDM, pre-
eclampsia, cesarean section, preterm birth, and SGA. For GH and LGA,
no studies had to be excluded from the meta‐analyses. By excluding
the insignificant results of the studies with a high risk of bias, the
increased risk for GH and LGA became stronger.20,26
4 | DISCUSSION
In this systematic review and meta‐analysis, data is pooled of over 1
million women covering the entire BMI spectrum and various
geographical regions. In all BMI categories, interpregnancy BMI gain
resulted in a higher incidence rate of GDM, GH, preeclampsia,
cesarean section, and LGA. Women with underweight and normal
weight were more affected by weight gain compared to women with
overweight or obesity in terms of risk for GDM, GH, and cesarean
section. Interpregnancy BMI loss was associated with a decreased risk
of LGA independently of BMI category, and with a decreased risk of
GDM in women with overweight or obesity before the first
pregnancy. No protective effect of weight loss was found for the
other perinatal outcomes, whereas an adverse effect of weight loss—
demonstrated by higher SGA and preterm birth incidence—was found.
This review is innovative in the approach to study weight change
between pregnancies. It is demonstrated that weight gain between
pregnancies increases the risk for perinatal complications. Interest-
ingly, the effects of interpregnancy weight change were dependent
on the initial BMI of women before conception. Previous studies
have already demonstrated that a higher BMI before conception is
associated with a higher risk of GDM, GH, preeclampsia, cesarean
section, and LGA.3,45,46 Furthermore, it has been demonstrated that
excessive gestational weight gain is associated with an increased risk
of perinatal complications.1,47,48 The results from the current review
provide the insight that it is not merely the static weight status
before conception and gestational weight gain that negatively influ-
ence perinatal outcomes. Weight change in the period immediately
prior to pregnancy also has a significant impact on perinatal
outcomes. The findings of the current review are in line with the
results of the review of Oteng‐Ntim et al who considered the effect
of interpregnancy weight change.49 Both reviews found that
interpregnancy weight gain is related to an increased risk of GDM,
cesarean section, and LGA. Moreover, the current systematic review
provides new insights on additional perinatal outcomes including GH,
preeclampsia, and preterm birth. Furthermore, a meta‐regression is
included in this review that showed differences in effects between
subgroups indicating a dose‐dependent effect of interpregnancy
weight gain. Contrasting results were found regarding the effect of
interpregnancy weight loss on GDM. Oteng‐Ntim et al described a
decreased risk of GDM when losing weight between pregnancies
whereas the current review only demonstrated this effect in women
with overweight or obesity before the first pregnancy. This
difference might be explained by the inclusion of a larger number
of studies in the current review.
The results of this systematic review provide evidence for the
impact of weight gain between pregnancies, but might also be relevant
for primigravidae. When the adverse effects of interpregnancy weight
gain are extrapolated to weight gain in the years before the first
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pregnancy, the change from normal weight to overweight and obesity
frequently found in this specific life phase is worrisome. Data derived
from population surveys in the USA show that obesity prevalence
almost doubles, from 21% in female adolescents (12‐19 years of age)
to 37% in women of 20 to 39 years of age. This underscores the high
risk for gaining weight at reproductive age.50,51 This distinct increase
in overweight and obesity prevalence from childhood to adolescence
is also evident in Europe, Asia, and South America.52-55
The prevalence of BMI gain in the studies included in this
systematic review indicates that a significant number of women are
at risk for interpregnancy BMI gain and thus for an increase
in perinatal complications, as 32% to 53% of women had a BMI gain
of at least 1 kg/m2.16,21-24,27 Determinants for interpregnancy BMI
gain in the studies included in this review were a younger maternal
age, longer interpregnancy interval, a lower educational level,
and preeclampsia, GH, and a cesarean section during the
first pregnancy.21,23,24,27 Regarding other factors with a potential
impact, consensus was not reached on risk factors such as no
breastfeeding, smoking, parity, lack of sleeping time, lack of exercise
in the postpartum period, and higher prepregnancy BMI.56-58
While interpregnancy weight gain is associated with an increased
risk for several adverse perinatal outcomes, weight loss between
pregnancies only resulted in a reduced risk of limited perinatal
complications. Since several studies found evidence for the
relationship between overweight/obesity and GH, preeclampsia,
cesarean section, and preterm birth,3,45,48 the finding that weight loss
only resulted in limited protective effects on these perinatal health
risks was unexpected. A possible explanation might be that although
BMI reduced in women classified in the “weight loss” group in the
studies, the total BMI loss of >1 kg/m2 without further stratification
was too small to have an effect on complications. A larger degree of
weight loss, a shift in BMI category from overweight or obesity to
normal weight, was not found to decrease the risk of preeclampsia,
cesarean section and preterm birth, either.19,29,36 From the studies
included in this systematic review, it is unclear which factors
contributed to the weight loss that was observed.
This comprehensive systematic review merged data from more
than 1 million women globally of which 745,993 women could be
included in the meta‐analysis. This large sample size allows strong
conclusions to be drawn from the results. However, some critical
remarks need to be considered. First, only a subset of studies could
be included in the meta‐analyses. Those studies were all classified as
having a low or moderate risk of bias and a large part of the total
number of participants could be included in the meta‐analyses, which
underscores the ability to draw strong conclusions from it. Second,
definitions of several outcome measures were heterogeneous. Apart
from the differences in inclusion criteria between studies, this may
have contributed to the statistical and between‐study heterogeneity.
Furthermore, the broad time frame (1959‐2017) in which included
studies collected their data might have contributed to the
heterogeneity between studies due to changes in society and public
health practices. On the other hand, our limited exclusion criteria
enhance the generalizability of our findings. Second, although several
confounders were considered in most studies, potential other con-
founders such as lifestyle behaviors could have influenced the risk
on perinatal complications. In addition, the adjustment for
confounders was variable across studies.
In summary, the findings of this meta‐analysis imply that, in current
clinical and research practice on prevention of adverse perinatal out-
comes, the focus on specific target groups could be extended. First,
our findings indicate that limiting gestational weight gain should not
be an exclusive target, but that prevention of weight gain in the
interpregnancy period should also be emphasized. In the light of the
growing prevalence rates of obesity in women of childbearing age, it
is important to start targeting women in the years before conception.
As gestational weight gain is part of the interpregnancy weight
change, limiting gestational weight gain should of course not be
neglected in prevention strategies.56 Second, women with normal
weight currently tend to escape our attention.59 Data aggregated in
this systematic review stresses the importance of targeting prevention
strategies not only on women with overweight and obesity but also on
women of normal weight. Third, further research should focus on
defining determinants that predict the benefits to be derived from
prevention of weight gain, thus allowing targeting specific prevention
strategies at those women most at risk. Finally, it was found that pre-
vention strategies should aim at prevention of weight gain in the years
before conception and between pregnancies rather than at stimulating
weight loss. Due to the lack of studies regarding the effects of these
targets, it is recommended to prospectively examine the effects of
the prevention of prepregnancy weight gain in women of all BMI
categories on perinatal outcomes by a randomized controlled trial,
taken into account the potential determinants of weight gain. These
studies might be the way forward in the prevention of adverse perina-
tal outcomes.
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